The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills
Launched by SAGLIK BILIMLERI UNIVERSITESI · Jul 29, 2023
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how personalized education can help adult patients with End Stage Renal Disease (ESRD) who are on hemodialysis. The researchers want to see if using a special teaching method called the "Teach-Back Method" can improve patients' ability to follow their treatment plan. This includes sticking to their fluid and diet restrictions and taking their medications as prescribed. Nurses will guide the education sessions, helping patients develop better coping skills related to their condition.
To participate in this study, candidates need to be between 18 and 65 years old, have been on hemodialysis for at least three months, and be able to communicate in Turkish. They should not have any severe speech, vision, or hearing problems, and must not have cognitive issues like dementia. If they agree to participate, they will receive individualized education and support to improve their health management. This trial is not yet recruiting participants, but it aims to help patients better manage their illness and improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemodialysis treatment for 4 hours, three times a week for at least 3 months with a diagnosis of end-stage renal failure,
- • Individuals between the ages of 18 and 65 years,
- • Having no speech, vision or hearing problems,
- • Be able to speak, read and write in Turkish,
- • Patients who have voluntarily to participate and informed consent form in the study.
- Exclusion Criteria:
- • Those who do not participate or agree to participate in training,
- • The general situation is not suitable for questioning,
- • Those diagnosed with a cognitive disease such as dementia.
About Saglik Bilimleri Universitesi
Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Elif Acar, Msc.
Principal Investigator
University of Health science
Semiha Akın, Prof.
Principal Investigator
University of Health science
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported